Robbins & Myers has an attractive current valuation of $48 per share, leaving it at only 24x its earnings per share over the past four quarters.
It is a relatively low-beta stock at 0.80, while outperforming the S&P 500 by over 27% over the past four weeks, and a staggering 17% over the past one week!
Its current fiscal year earnings estimate has been revised by analysts by approximately 15%. RBN has also had a healthy number of EPS surprises in its history, averaging a +6% surprise over the past nine quarters.
We like RBNs growth rate and valuation, and set a price target of $54 per share over a one-month period.